Literature DB >> 11284991

Prevalence of Alzheimer's type dementia in an elderly Arab population.

A Bowirrat1, T A Treves, R P Friedland, A D Korczyn.   

Abstract

The aim of this study was to estimate the prevalence of dementia of the Alzheimer type (DAT) in an Arab Israeli community. Epidemiological studies of dementia have rarely been reported in Arab populations. The target population, aged 60 years or older, comprised 821 persons (362 males) who, on 1 October 1995, were residents of the rural area of Wadi Ara. These persons were examined for symptoms of dementia (DSM-IV criteria), using a semistructured questionnaire for collection of demographic and medical data. Age, gender, and education-specific prevalence rates were calculated for this population and compared to those obtained in other studies. DAT was diagnosed in 20.5% of this population. Its prevalence increased steeply with age, from 8% among those younger than 70 years to 33% among those aged 70-79 and 51% among those 80 years or older. Illiteracy was very common in this population, and strongly associated with higher prevalence of DAT (27% vs. 4%, P < 0.001). DAT was more prevalent among females than males (25% vs. 15%, P < 0.001). However, illiteracy was also significantly more frequent among women (96% vs. 42%, P < 0.001). After correction for illiteracy, the gender difference lost statistical significance. Few women smoked, but among men, the prevalence of DAT in those who smoked was lower as compared to non-smokers (14% vs. 23%, a non-significant difference). These results were confirmed by logistic regression wherein DAT was included as the dependent variable and age, illiteracy, gender and smoking as independent variables (OR=2.8, 2.8, 1.2 and 0.7, respectively; P < 0.005 for each, except for smoking). Our findings suggest that this population is unique because of extremely high rates of dementia. While the results support a protective effect of schooling against the development of dementia, other factors (e.g. genetic) must be sought to explain this high frequency.

Entities:  

Mesh:

Year:  2001        PMID: 11284991     DOI: 10.1046/j.1468-1331.2001.00183.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  24 in total

1.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

Review 3.  Relationship between education and dementia: an updated systematic review.

Authors:  Emily Schoenhofen Sharp; Margaret Gatz
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

4.  Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data.

Authors:  Richard Sherva; Clinton T Baldwin; Rivka Inzelberg; Badri Vardarajan; L Adrienne Cupples; Kathryn Lunetta; Abdalla Bowirrat; Adam Naj; Margaret Pericak-Vance; Robert P Friedland; Lindsay A Farrer
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community.

Authors:  Yan Meng; Clinton T Baldwin; Abdalla Bowirrat; Kristin Waraska; Rivka Inzelberg; Robert P Friedland; Lindsay A Farrer
Journal:  Am J Hum Genet       Date:  2006-03-16       Impact factor: 11.025

6.  Estimating the risk for conversion from mild cognitive impairment to Alzheimer's disease in an elderly Arab community.

Authors:  Rivka Inzelberg; Magda Massarwa; Edna Schechtman; Rosa Strugatsky; Lindsay A Farrer; Robert P Friedland
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  High prevalence of mild cognitive impairment and Alzheimer's disease in arabic villages in northern Israel: impact of gender and education.

Authors:  Anne E Afgin; Magda Massarwa; Edna Schechtman; Simon D Israeli-Korn; Rosa Strugatsky; Amin Abuful; Lindsay A Farrer; Robert P Friedland; Rivka Inzelberg
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

8.  Validation of the 10/66 Dementia Research Group diagnostic assessment for dementia in Arabic: a study in Lebanon.

Authors:  Kieu T T Phung; Monique Chaaya; Gunhild Waldemar; Samir Atweh; Khalil Asmar; Husam Ghusn; Georges Karam; Raja Sawaya; Rose Mary Khoury; Ibrahim Zeinaty; Sandrine Salman; Salem Hammoud; Wael Radwan; Nazem Bassil; Martin Prince
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-04-25       Impact factor: 2.680

9.  Contact frequency and cognitive health among older adults in Israel.

Authors:  Ella Schwartz; Rabia Khalaila; Howard Litwin
Journal:  Aging Ment Health       Date:  2018-05-03       Impact factor: 3.658

10.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Authors:  Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.